Inventor · disambiguated record
Mario Amendola
Also filed as: AMENDOLA MARIO
2 granted patents·7 pending applications·7 citations·filing 2004–2021
46Inventor score
Top patents by PatentIndex Score
9 records- 0175US8501464B2Lentiviral vectors carrying synthetic bi-directional promoters and uses thereofNALDINI LUIGI·Filed 2004·Granted Aug 6, 2013·7 cites·16 claims
- 0251US2023357769A1Bifunctional lentiviral vectors allowing the bs-globin silencing and expression of an anti-sickling hbb and uses thereof for gene therapy of sickle cell diseaseINST NAT SANTE RECH MED·Filed 2021·Application pending·0 cites
- 0350US2023272433A1Enhancing Utrophin Expression in Cell by Inducing Mutations Within Utrophin Regulatory Elements and Therapeutic Use ThereofGENETHON·Filed 2021·Application pending·0 cites
- 0448US2024067942A1Lysosomal acid lipase variants and uses thereofGENETHON·Filed 2021·Application pending·0 cites
- 0545US2022160788A1Bifunctional vectors allowing bcl11a silencing and expression of an anti-sickling hbb and uses thereof for gene therapy of b-hemoglobinopathiesINST NAT SANTE RECH MED·Filed 2020·Application pending·0 cites
- 0642US2022184137A1Correction of Beta-Thalassemia Phenotype by Genetically Engineered Hematopoietic Stem CellINST NAT SANTE RECH MED·Filed 2020·Application pending·0 cites
- 0742US2022017919A1Recombinant vectors suitable for the treatment of ipex syndromeINST NAT SANTE RECH MED·Filed 2019·Application pending·0 cites
- 0840US12012613B2Genetically engineered hematopoietic stem cell as a platform for systemic protein expressionGENETHON·Filed 2019·Granted Jun 18, 2024·0 cites·13 claims
- 0940US2022136006A1Recombinant vectors suitable for the treatment of ipex syndromeINST NAT SANTE RECH MED·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Mario Amendola files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →